-
1.
公开(公告)号:US20090011464A1
公开(公告)日:2009-01-08
申请号:US12214304
申请日:2008-06-18
申请人: Paul D. Ponath , Douglas J. Ringler , S. Tarran Jones , Walter Newman , Jose Saldanha , Mary M. Bendig
发明人: Paul D. Ponath , Douglas J. Ringler , S. Tarran Jones , Walter Newman , Jose Saldanha , Mary M. Bendig
摘要: The present invention relates to isolated nucleic acids encoding humanized immunoglobulins having binding specificity for α4β7 integrin, isolated nucleic acids encoding a humanized immunoglobulin heavy chain and isolated nucleic acids encoding a humanized light chain having binding specificity for α4β7 integrin. The invention also relates to expression vectors and host cells comprising a nucleotide sequence which encodes a humanized immunoglobulin or antigen-binding fragment thereof having binding specificity for α4β7. The invention further relates to methods of preparing a humanized immunoglobulin, humanized immunoglobulin heavy chain and humanized immunoglobulin light chain that has binding specificity for α4β7 integrin.
摘要翻译: 本发明涉及编码对α4β7整联蛋白具有结合特异性,编码人源化免疫球蛋白重链的分离的核酸和编码具有α4β7整联蛋白的结合特异性的人源化轻链的分离的核酸的分离的核酸。 本发明还涉及包含编码具有对α4β7具有结合特异性的人源化免疫球蛋白或其抗原结合片段的核苷酸序列的表达载体和宿主细胞。 本发明还涉及制备对α4β7整联蛋白具有结合特异性的人源化免疫球蛋白,人源化免疫球蛋白重链和人源化免疫球蛋白轻链的方法。
-
公开(公告)号:US07402410B2
公开(公告)日:2008-07-22
申请号:US11511164
申请日:2006-08-28
申请人: Paul D. Ponath , Douglas J. Ringler , S. Tarran Jones , Walter Newman , José Saldanha , Mary M. Bendig
发明人: Paul D. Ponath , Douglas J. Ringler , S. Tarran Jones , Walter Newman , José Saldanha , Mary M. Bendig
CPC分类号: C07K16/2839 , A61K38/00 , C07K14/70503 , C07K2317/24 , C07K2319/00
摘要: The present invention relates to isolated nucleic acids encoding humanized immunoglobulins having binding specificity for α4β7 integrin, isolated nucleic acids encoding a humanized immunoglobulin heavy chain and isolated nucleic acids encoding a humanized light chain having binding specificity for α4β7 integrin. The invention also relates to expression vectors and host cells comprising a nucleotide sequence which encodes a humanized immunoglobulin or antigen-binding fragment thereof having binding specificity for α4β7. The invention further relates to methods of preparing a humanized immunoglobulin, humanized immunoglobulin heavy chain and humanized immunoglobulin light chain that has binding specificity for α4β7 integrin.
摘要翻译: 本发明涉及编码对α4β7整联蛋白具有结合特异性,编码人源化免疫球蛋白重链的分离的核酸和编码具有α4β7整联蛋白的结合特异性的人源化轻链的分离的核酸的分离的核酸。 本发明还涉及包含编码具有对α4β7具有结合特异性的人源化免疫球蛋白或其抗原结合片段的核苷酸序列的表达载体和宿主细胞。 本发明还涉及制备对α4β7整联蛋白具有结合特异性的人源化免疫球蛋白,人源化免疫球蛋白重链和人源化免疫球蛋白轻链的方法。
-
公开(公告)号:US07147851B1
公开(公告)日:2006-12-12
申请号:US08700737
申请日:1996-08-15
申请人: Paul D. Ponath , Douglas J. Ringler , S. Tarran Jones , Walter Newman , José Saldanha , Mary M. Bendig
发明人: Paul D. Ponath , Douglas J. Ringler , S. Tarran Jones , Walter Newman , José Saldanha , Mary M. Bendig
IPC分类号: A61K39/395 , C07K16/28 , C07K16/18
CPC分类号: C07K16/2839 , A61K38/00 , C07K14/70503 , C07K2317/24 , C07K2319/00
摘要: The present invention relates to humanized immunoglobulins having binding specificity for α4β7 integrin, comprising an antigen binding region of nonhuman origin (e.g., rodent) and at least a portion of an immunoglobulin of human origin (e.g., a human framework region, a human constant region). In one embodiment, the humanized immunoglobulin can compete with murine Act-1 for binding to human α4β7 integrin. In a preferred embodiment, the antigen binding region of the humanized immunoglobulin comprises each of the complementarity determining regions of the light and heavy chains of the murine Act-1 antibody.
-
4.
公开(公告)号:US5840299A
公开(公告)日:1998-11-24
申请号:US561521
申请日:1995-11-21
IPC分类号: C12N15/09 , A61K31/00 , A61K38/00 , A61K39/395 , A61P1/00 , A61P1/04 , A61P3/00 , A61P3/10 , A61P7/00 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/06 , A61P13/00 , A61P13/12 , A61P17/00 , A61P17/06 , A61P25/28 , A61P29/00 , A61P35/00 , A61P35/04 , A61P37/00 , C07H21/04 , C07K20060101 , C07K16/18 , C07K16/28 , C07K16/46 , C12N5/00 , C12N5/10 , C12N15/13 , C12P21/08 , C12R1/91 , G01N33/53
CPC分类号: C07K16/2842 , C07K16/2839 , A61K2039/505 , A61K38/00 , C07K2317/24 , C07K2319/00
摘要: The invention provides humanized immunoglobulins that specifically bind to the VLA-4 ligand, and methods of treatment using the same. The methods are particularly useful for treatment of multiple sclerosis.
摘要翻译: 本发明提供了特异性结合VLA-4配体的人源化免疫球蛋白及其使用的治疗方法。 该方法对于多发性硬化症的治疗特别有用。
-
公开(公告)号:US5800815A
公开(公告)日:1998-09-01
申请号:US202047
申请日:1994-02-25
申请人: Robert W. Chestnut , Margaret J. Polley , James C. Paulson , S. Tarran Jones , Jose W. Saldanha , Mary M. Bendig , Michael Kriegler , Carl Perez , Robert Bayer , Michael Nunn
发明人: Robert W. Chestnut , Margaret J. Polley , James C. Paulson , S. Tarran Jones , Jose W. Saldanha , Mary M. Bendig , Michael Kriegler , Carl Perez , Robert Bayer , Michael Nunn
IPC分类号: A61K38/00 , C07K14/705 , C07K16/28 , A61K39/395 , C07H21/04 , C12N5/12
CPC分类号: C07K16/2854 , C07K14/70564 , A61K2039/505 , A61K38/00 , C07K2317/24 , C07K2317/34 , C07K2319/00
摘要: The present invention relates to compositions and methods for treating inflammation and other pathological conditions using novel blocking P-selectin antibodies that inhibit adhesion of leukocytes to activated platelets and/or to activated vascular endothelium in vivo. Both murine and humanized antibodies are provided.
摘要翻译: 本发明涉及使用抑制白细胞粘附于活化血小板和/或体内活化血管内皮的新型阻断P-选择素抗体来治疗炎症和其它病理状况的组合物和方法。 提供鼠和人源化抗体。
-
公开(公告)号:US6033667A
公开(公告)日:2000-03-07
申请号:US964690
申请日:1997-11-05
申请人: Robert W. Chesnut , Margaret J. Polley , James C. Paulson , S. Tarran Jones , Jose W. Saldanha , Mary M. Bendig , Michael Kriegler , Carl Perez , Robert Bayer , Michael Nunn
发明人: Robert W. Chesnut , Margaret J. Polley , James C. Paulson , S. Tarran Jones , Jose W. Saldanha , Mary M. Bendig , Michael Kriegler , Carl Perez , Robert Bayer , Michael Nunn
CPC分类号: C07K16/2854 , A61K2039/505 , C07K2317/24 , C07K2317/34 , C07K2319/00
摘要: The present invention relates to compositions and methods for treating inflammation and other pathological conditions using novel blocking P-selectin antibodies that inhibit adhesion of leukocytes to activated platelets and/or to activated vascular endothelium in vivo. Both murine and humanized antibodies are provided.
摘要翻译: 本发明涉及使用抑制白细胞粘附于活化血小板和/或体内活化血管内皮的新型阻断P-选择素抗体来治疗炎症和其它病理状况的组合物和方法。 提供鼠和人源化抗体。
-
公开(公告)号:US20130071381A1
公开(公告)日:2013-03-21
申请号:US13528407
申请日:2012-06-20
申请人: Gregory J. LaRosa , Christopher J. Horvath , Walter Newman , S. Tarran Jones , Siobhan H. O'Brien , Theresa O'Keefe
发明人: Gregory J. LaRosa , Christopher J. Horvath , Walter Newman , S. Tarran Jones , Siobhan H. O'Brien , Theresa O'Keefe
IPC分类号: C07K16/28
CPC分类号: C07K16/2866 , A61K2039/505 , C07K14/7158 , C07K2317/24 , C07K2317/33 , C07K2317/565 , C07K2317/567 , C07K2317/76 , C07K2319/00
摘要: The present invention relates to a humanized antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 2 (CCR2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the interaction of a cell bearing mammalian CCR2 with a ligand thereof, and to use of the antibodies and fragments in therapeutic, prophylactic and diagnostic methods.
-
公开(公告)号:US20080241136A1
公开(公告)日:2008-10-02
申请号:US11924794
申请日:2007-10-26
申请人: Gregory J. LaRosa , Christopher J. Horvath , Walter Newman , S. Tarran Jones , Siobhan H. O'Brien , Theresa O'Keefe
发明人: Gregory J. LaRosa , Christopher J. Horvath , Walter Newman , S. Tarran Jones , Siobhan H. O'Brien , Theresa O'Keefe
IPC分类号: A61K39/395
CPC分类号: C07K16/2866 , A61K2039/505 , C07K2317/76
摘要: The present invention relates to a humanized antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 2 (CCR2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the interaction of a cell bearing mammalian CCR2 with a ligand thereof, and to use of the antibodies and fragments in therapeutic, prophylactic and diagnostic methods.
-
公开(公告)号:US07566450B2
公开(公告)日:2009-07-28
申请号:US11924794
申请日:2007-10-26
申请人: Gregory J. LaRosa , Christopher J. Horvath , Walter Newman , S. Tarran Jones , Siobhan H. O'Brien , Theresa O'Keefe
发明人: Gregory J. LaRosa , Christopher J. Horvath , Walter Newman , S. Tarran Jones , Siobhan H. O'Brien , Theresa O'Keefe
IPC分类号: A61K39/395
CPC分类号: C07K16/2866 , A61K2039/505 , C07K2317/76
摘要: The present invention relates to a humanized antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 2 (CCR2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the interaction of a cell bearing mammalian CCR2 with a ligand thereof, and to use of the antibodies and fragments in therapeutic, prophylactic and diagnostic methods.
-
公开(公告)号:US20080241923A1
公开(公告)日:2008-10-02
申请号:US11924153
申请日:2007-10-25
申请人: Gregory J. LaRosa , Christopher J. Horvath , Walter Newman , S. Tarran Jones , Siobhan H. O'Brien , Theresa O'Keefe
发明人: Gregory J. LaRosa , Christopher J. Horvath , Walter Newman , S. Tarran Jones , Siobhan H. O'Brien , Theresa O'Keefe
IPC分类号: C12N5/06
CPC分类号: C07K16/2866 , A61K2039/505 , C07K2317/76
摘要: The present invention relates to a humanized antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 2 (CCR2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the interaction of a cell bearing mammalian CCR2 with a ligand thereof, and to use of the antibodies and fragments in therapeutic, prophylactic and diagnostic methods.
-
-
-
-
-
-
-
-
-